It has been demonstrated that the BCR–ABL oncoprotein up-regulates HSP70 by binding the GATA–RE element to the HSP70 promoter region in chronic myelogenous leukemia (CML). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.